Stock listing
LSE:GDR Genedrive PLC Share Price
Home listing (LSE) of Genedrive PLC
Follow Genedrive PLC into a list and get an email when it puts out news.
Share price · LSE:GDR
0.85p GBX (pence) -0.05 (-5.6%)
Close on Nov 20, 2026
- Day range
- 0.80p – 0.90p GBX (pence)Nov 20, 2026
- Volume
- 5.38M sharesNov 20, 2026
- Market cap
- £13.65M GBPAt the close on Nov 20, 2026 · price × 1.61B shares outstanding
- 52-week range
- 0.715p – 1.55p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- £40,102 GBPMedian day 2.62M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:GDR · Home | 0.85p GBX (pence) | -0.05 (-5.6%) | 5,383,624 | 0.90p | 0.90p | 0.80p | 0.90p | Close on Nov 20, 2026 |
| Frankfurt:D6M | €0.01 EUR | 0.00 (0.0%) | — | €0.01 | €0.01 | €0.01 | €0.01 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:GDR · GBX (pence), adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.85p | -0.05 | -5.6% | 0.90p | 0.90p | 0.80p | 5,383,624 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 0.90p | 0.875p | 2,487,950 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 0.95p | 0.85p | 63,256 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 0.95p | 0.85p | 700,451 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 0.95p | 0.876p | 1,913,919 | |
| 0.90p | 0.00 | 0.0% | 0.90p | 0.95p | 0.878p | 1,522,574 | |
| 0.90p | +0.025 | +2.9% | 0.875p | 0.95p | 0.85p | 2,470,801 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.85p | 4,134,101 | |
| 0.875p | 0.00 | 0.0% | 0.875p | 0.95p | 0.85p | 2,586,669 | |
| 0.875p | -0.10 | -10.3% | 0.95p | 1.00p | 0.855p | 7,820,117 | |
| 0.975p | 0.00 | 0.0% | 0.95p | 1.00p | 0.95p | 3,273,022 | |
| 0.975p | +0.025 | +2.6% | 0.95p | 1.00p | 0.93p | 4,286,562 | |
| 0.95p | -0.025 | -2.6% | 0.975p | 1.00p | 0.90p | 2,070,055 | |
| 0.975p | 0.00 | 0.0% | 0.975p | 1.00p | 0.965p | 2,351,199 | |
| 0.975p | 0.00 | 0.0% | 0.975p | 1.00p | 0.965p | 1,288,163 | |
| 0.975p | -0.025 | -2.5% | 1.00p | 1.05p | 0.965p | 2,013,639 | |
| 1.00p | 0.00 | 0.0% | 1.00p | 1.05p | 0.95p | 2,395,494 | |
| 1.00p | -0.025 | -2.4% | 1.025p | 1.05p | 0.945p | 2,447,416 | |
| 1.025p | -0.075 | -6.8% | 1.095p | 1.095p | 1.00p | 3,635,750 | |
| 1.10p | +0.025 | +2.3% | 1.075p | 1.15p | 1.033p | 2,898,418 | |
| 1.075p | 0.00 | 0.0% | 1.075p | 1.09p | 1.031p | 227,983 | |
| 1.075p | 0.00 | 0.0% | 1.075p | 1.15p | 1.03p | 225,567 | |
| 1.075p | 0.00 | 0.0% | 1.075p | 1.14p | 1.00p | 678,594 | |
| 1.075p | +0.025 | +2.4% | 1.05p | 1.15p | 1.00p | 1,269,451 | |
| 1.05p | -0.05 | -4.5% | 1.10p | 1.12p | 1.01p | 4,359,996 | |
| 1.10p | +0.05 | +4.8% | 1.10p | 1.15p | 1.05p | 1,230,437 | |
| 1.05p | -0.025 | -2.3% | 1.075p | 1.15p | 1.05p | 1,150,153 | |
| 1.075p | -0.025 | -2.3% | 1.10p | 1.15p | 1.075p | 3,525,214 | |
| 1.10p | -0.05 | -4.3% | 1.20p | 1.20p | 1.05p | 4,919,486 | |
| 1.15p | 0.00 | 0.0% | 1.15p | 1.173p | 1.122p | 432,345 | |
| 1.15p | 0.00 | 0.0% | 1.15p | 1.18p | 1.10p | 1,865,891 | |
| 1.15p | -0.025 | -2.1% | 1.175p | 1.25p | 1.10p | 2,157,812 | |
| 1.175p | 0.00 | 0.0% | 1.175p | 1.25p | 1.125p | 2,619,985 | |
| 1.175p | 0.00 | 0.0% | 1.175p | 1.20p | 1.116p | 3,805,447 | |
| 1.175p | -0.025 | -2.1% | 1.20p | 1.25p | 1.15p | 2,606,746 | |
| 1.20p | 0.00 | 0.0% | 1.20p | 1.25p | 1.15p | 2,827,987 | |
| 1.20p | +0.025 | +2.1% | 1.175p | 1.25p | 1.15p | 4,228,550 | |
| 1.175p | -0.025 | -2.1% | 1.20p | 1.233p | 1.15p | 3,329,222 | |
| 1.20p | 0.00 | 0.0% | 1.20p | 1.25p | 1.10p | 6,253,554 | |
| 1.20p | +0.025 | +2.1% | 1.175p | 1.24p | 1.15p | 2,145,325 | |
| 1.175p | -0.025 | -2.1% | 1.20p | 1.25p | 1.15p | 3,603,057 | |
| 1.20p | +0.05 | +4.3% | 1.175p | 1.25p | 1.15p | 2,881,128 | |
| 1.15p | -0.075 | -6.1% | 1.20p | 1.25p | 1.15p | 1,498,355 | |
| 1.225p | -0.025 | -2.0% | 1.225p | 1.25p | 1.20p | 6,344,456 | |
| 1.25p | 0.00 | 0.0% | 1.25p | 1.30p | 1.20p | 5,738,171 | |
| 1.25p | 0.00 | 0.0% | 1.25p | 1.29p | 1.20p | 3,249,872 | |
| 1.25p | 0.00 | 0.0% | 1.225p | 1.30p | 1.20p | 1,905,939 | |
| 1.25p | -0.025 | -2.0% | 1.275p | 1.30p | 1.20p | 3,852,365 | |
| 1.275p | -0.025 | -1.9% | 1.30p | 1.35p | 1.25p | 1,553,849 | |
| 1.30p | 0.00 | 0.0% | 1.30p | 1.35p | 1.27p | 12,222,263 | |
| 1.30p | -0.025 | -1.9% | 1.40p | 1.40p | 1.25p | 1,067,251 | |
| 1.325p | +0.025 | +1.9% | 1.30p | 1.35p | 1.25p | 6,346,424 | |
| 1.30p | -0.05 | -3.7% | 1.35p | 1.375p | 1.255p | 3,653,041 | |
| 1.35p | -0.025 | -1.8% | 1.375p | 1.45p | 1.30p | 3,136,892 | |
| 1.375p | 0.00 | 0.0% | 1.375p | 1.45p | 1.30p | 1,612,694 | |
| 1.375p | 0.00 | 0.0% | 1.375p | 1.50p | 1.30p | 11,258,889 | |
| 1.375p | -0.025 | -1.8% | 1.40p | 1.45p | 1.30p | 1,115,429 | |
| 1.40p | 0.00 | 0.0% | 1.40p | 1.55p | 1.35p | 10,964,144 | |
| 1.40p | +0.075 | +5.7% | 1.325p | 1.40p | 1.25p | 4,942,826 | |
| 1.325p | 0.00 | 0.0% | 1.325p | 1.40p | 1.25p | 777,076 | |
| 1.325p | +0.025 | +1.9% | 1.30p | 1.40p | 1.25p | 864,851 | |
| 1.30p | -0.08 | -5.8% | 1.375p | 1.40p | 1.25p | 3,125,127 | |
| 1.38p | +0.08 | +6.2% | 1.30p | 1.40p | 1.25p | 12,404,644 | |
| 1.30p | -0.05 | -3.7% | 1.35p | 1.40p | 1.26p | 5,229,933 | |
| 1.35p | +0.10 | +8.0% | 1.25p | 1.40p | 1.245p | 5,533,595 |
- Ticker
- LSE:GDR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- LSE
- Currency
- GBX
What changed lately
Latest news release · Oct 12, 2026
NIHR highlights genedrive's rapid genetic test
Latest earnings call · Dec 8, 2025
Genedrive (LSE:GDR) — Full year results briefing
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 20 slides
Calls
Replays
Genedrive (LSE:GDR) — Full year results briefing
Mon, Dec 08, 2025 · 9:00 AM ET
Watch TranscriptGenedrive (LSE:GDR) — Full year results briefing
Mon, Dec 02, 2024 · 9:00 AM ET
Watch TranscriptGenedrive (LSE:GDR) — Interim results presentation
Fri, Apr 05, 2024 · 5:00 AM ET
Watch Transcript
Latest news
NIHR highlights genedrive's rapid genetic test
Oct 12, 2026
Closed 1.10p (-4.3%) on Oct 12, 2026
Welsh hospitals extend routine MT-RNR1 testing
Sep 10, 2026
Closed 1.30p (-1.9%) on Sep 10, 2026
ShareSoc Investor Presentation Reminder
Sep 3, 2026
Closed 1.38p (0.0%) on Sep 3, 2026
Director/PDMR Notification
Sep 1, 2026
Closed 1.40p (0.0%) on Sep 1, 2026
Board Appointments
Aug 21, 2026
Closed 1.30p (-3.7%) on Aug 21, 2026
ShareSoc Investor Presentation
Aug 13, 2026
Closed 1.20p (0.0%) on Aug 13, 2026
Completion of PALOH-UK Patient Recruitment
Aug 11, 2026
Closed 1.20p (+4.3%) on Aug 11, 2026
MT-RNR1 test implemented in the Netherlands
Aug 4, 2026
Closed 1.15p (+15.0%) on Aug 4, 2026
New UK clinical guideline for MT-RNR1 testing
Aug 3, 2026
Closed 1.00p (0.0%) on Aug 3, 2026
UK Minister highlights pharmacogenetic testing
Jul 10, 2026
Closed 1.28p (+4.1%) on Jul 10, 2026
Financings
Private placement of placing Shares
Feb 19, 2026 · US$681,872
Update: £500,000 · GBX 1 a share · Peel Hunt LLP
Dealers: Peel Hunt LLP (lead)
Private placement of firm Subscription Shares
Feb 19, 2026 · US$4.77M
Tranche closed: £3.5M raised · GBX 1 a share
Rights offering of open Offer Shares
Feb 19, 2026 · US$2.02M
Update: up to £1.5M · GBX 1 a share · Peel Hunt LLP
Dealers: Peel Hunt LLP (lead)
Buyers: Dr. Gino Miele (intends to subscribe for £50,000 worth of Open Offer Shares); Russ Shaw (intends to subscribe for £50,000 worth of Open Offer Shares)
Insiders: CEO Dr. Gino Miele and CFO Russ Shaw each intend to subscribe for £50,000 worth of Open Offer Shares
New equity (institutional placing and open offer)
Jan 19, 2026 · US$8.05M
Announced: up to £6M
Buyers: David Nugent (intends to subscribe for £1.5m); Robert English (intends to subscribe for £1.5m)
Insiders: The Directors intend to invest not less than £100,000 in the Equity Raise; major shareholders David Nugent and Robert English intend to subscribe £1.5m each.
Use of proceeds: Commercialisation and market expansion in UK, Europe and Middle East, FDA 510(k) submission, manufacturing scale-up, product refinements and IP translation
Secured shareholder loan
Dec 9, 2025
Update: debt
Buyers: David Nugent (Lender of up to £1.0 million; intends to convert all drawn amounts into equity as part of a future equity raise)
Insiders: Loan provided by David Nugent, a significant shareholder and related party; constitutes a related party transaction under AIM Rule 13
Use of proceeds: Extend the Company's cash runway into February 2026
Private placement of new ordinary shares (Placing Shares)
Oct 9, 2025
Update: GBX 0.2 a share · 1 warrant at GBX 0.4 for 24 months · Peel Hunt LLP +1
Dealers: Peel Hunt LLP (co-lead), Allenby Capital Limited (co-lead)
Use of proceeds: Extend cash runway into Q2/Q3 2026, drive sales and move closer to potential launch in other markets including the US
Announced Sep 23, 2025 · Update Sep 29, 2025 · Update Oct 9, 2025
New ordinary shares (Retail Offer Shares)
Sep 23, 2025 · US$405,581
Announced: £300,000 · GBX 0.2 a share · 1 warrant at GBX 0.4 for 24 months · Allenby Capital Limited
Dealers: Allenby Capital Limited (lead)
Private placement of new Ordinary Shares
Apr 1, 2025
Closed: £1.23M raised · GBX 1.5 a share · free to trade Apr 3, 2025
Decks
Investor Presentation (September 2026)
Investor deck · 20 slides · September 2026
FY2025 Earnings Presentation
Earnings · 23 slides · Dec 8, 2025
VOX Markets Presentation 2020
Conference · 20 slides · Jun 12, 2020
H1 2018 Earnings Presentation
Earnings · 20 slides · Mar 20, 2018
Genedrive PLC on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 34 in the last 12 months · 284 in all · newest Oct 12, 2026 · oldest 2007
- Calls
- 9 calls with a replay · 9 with a transcript · latest Dec 8, 2025
- Decks
- 4 decks · latest September 2026
Where Genedrive PLC is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:GDR · Home listing · This page | LSE | United Kingdom | GBX |
| Aquis:GDRL | Aquis | United Kingdom | GBX |
| Frankfurt:D6M | Frankfurt | Germany | EUR |
| Stuttgart:D6M | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Genedrive PLC.